Microbotox injection versus oral isotretinoin tablets in treating patients with oily skin and acne-A comparative study.
Phase 2
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2024/07/071250
- Lead Sponsor
- Aishwarya Satyanarayana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients above the age of 18 years, with seborrhea which meets the criteria as per skin oiliness and acne which requires isotretinoin therapy. Patients who are willing to provide informed consent will be considered for participation in the study.
Exclusion Criteria
Patients with active infection at injection site, neuromuscular disorders, known hypersensitivity to any ingredient of the injection. Pregnant and lactating women. Patients on oral steroid therapy, anticoagulant therapy, systemic retinoid intake in the previous six months. Patients with unrealistic expectations.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the subjective seborrhea severity graded on a scale of 1 to 10, 1 being mild and 10 being severe from baseline to 3 months.Timepoint: Reduction in the subjective seborrhea severity at baseline, 4weeks, 8weeks and 12weeks.
- Secondary Outcome Measures
Name Time Method Reduction in the Comprehensive Acne Severity Score from baseline to 3 months.Timepoint: Baseline at 0weeks, follow up visits at 4,8,12 weeks.